Influenza A positive but H1N1 negative myocarditis in a patient coming from a high outbreak region of new influenza

Cardiology Journal

Volumn 18, Issue 4, 2011, Pages 441-445

  Himmel, Frank ^a   Hunold, Peter ^a   Schunkert, Heribert ^a   Bode, Frank ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

H1N1; Influenza A; Myocarditis

Indexed keywords

C REACTIVE PROTEIN; CREATINE KINASE; CREATINE KINASE MB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GADOLINIUM; LACTATE DEHYDROGENASE; NONSTEROID ANTIINFLAMMATORY AGENT; TROPONIN T;

ADULT; ARTICLE; CARDIAC IMAGING; CASE REPORT; CHILL; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTRAST ENHANCEMENT; DISEASE ASSOCIATION; DIZZINESS; DYSPNEA; EPIDEMIC; FALSE NEGATIVE RESULT; FATIGUE; FEVER; HEADACHE; HEART EDEMA; HUMAN; INFLUENZA A; INFLUENZA VIRUS A H1N1; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; RESPIRATORY TRACT DISEASE; SEROLOGY; T WAVE INVERSION; TRANSTHORACIC ECHOCARDIOGRAPHY; VIRUS MYOCARDITIS; VIRUS TRANSMISSION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL MARKERS; CREATINE KINASE, MB FORM; ELECTROCARDIOGRAPHY; HUMANS; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MAGNETIC RESONANCE IMAGING, CINE; MALE; MYOCARDITIS; SPAIN; TRAVEL; TREATMENT OUTCOME; TROPONIN T; YOUNG ADULT;

EID: 79960617638     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Rose NR. Myocarditis: Infection versus autoimmunity. J Clin Immunol, 2009; 29: 730-737.
2. Letouze N, Jokic M, Maragnes P et al. Fulminant influenza type A associated myocarditis: A fatal case in an 8 year old child. Arch Mal Coeur Vaiss, 2006; 99: 514-516.
3. Nolte KB, Alakija P, Oty G et al. Influenza A virus infection complicated by fatal myocarditis. Am J Forensic Med Pathol, 2000; 21: 375-379.
4. Montcriol A, Wiramus S, Ribeiri A et al. Successful management of Influenza A associated fulminant myocarditis: mobile circulatory support in intensive care unit: A case report. Cases J, 2008; 1: 46.
5. Steel J, Staeheli P, Mubareka S, Garcia-Sastre A, Palese P, Lowen AC. Transmission of pandemic H1N1 influenza virus and impact of prior exposure to seasonal strains or interferon treatment. J Virol, 2010; 84: 21-26.
6. Assomull RG, Lyne JC, Keenan N et al. The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin, and unobstructed coronary arteries. Eur Heart J, 2007; 28: 1242-1249.
7. Schnitzler SU, Schnitzler P. An update on swine-origin influenza virus A/H1N1: A review. Virus Genes, 2009; 39: 279-292.
8. Cooper LT, Baughman KL, Feldman AM et al. The role of en-domyocardial biopsy in the management of cardiovascular disease: A scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. J Am Coll Cardiol, 2007; 50: 1914-1931.
9. Feldman AM, McNamara D. Myocarditis. N Engl J Med, 2000; 343: 1388-1398.
10. Magnani JW, Dec GW. Myocarditis: Current trends in diagnosis and treatment. Circulation, 2006; 113: 876-890.
11. Al-Mallah M, Kwong RY. Clinical application of cardiac CMR. Rev Cardiovasc Med, 2009; 10: 134-141.
12. Dawood FS, Jain S, Finelli L et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med, 2009; 360: 2605-2615.
13. Cauchemez S, Donnelly CA, Reed C et al. Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. N Engl J Med, 2009; 361: 2619-2627.
14. Centers for Disease Control and Prevention (CDC). Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep, 2009; 58: 521-524.